NASDAQ:CCCC

C4 Therapeutics Insider Trades

$50.50
+0.45 (+0.90 %)
(As of 09/23/2021 04:00 PM ET)
Add
Compare
Today's Range
$49.55
$51.21
50-Day Range
$35.91
$50.50
52-Week Range
$22.40
$51.21
Volume218,535 shs
Average Volume361,793 shs
Market Capitalization$2.45 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

C4 Therapeutics (NASDAQ:CCCC) Insider Buying and Selling Activity

21.04% of C4 Therapeutics' shares are owned by company executives, directors and other insiders. Over the past twelve months, insiders at the have sold shares 15 time(s), totalling $7,496,932.52. During the same time, C4 Therapeutics insiders have purchased shares 2 time(s), totalling $195,567.00. Insiders that have bought shares include Marc A Cohen, and William Mckee. Insiders that have sold shares include Elena Prokupets, Malcolm Salter, Stewart Fisher, Jolie Siegel, and Adam Crystal.

Insider Buying and Selling by Quarter


C4 Therapeutics (NASDAQ CCCC) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/21/2021Elena ProkupetsDirectorSell10,321$50.14$517,494.94  
9/17/2021Elena ProkupetsDirectorSell10,840$50.05$542,542.00  
9/15/2021Elena ProkupetsDirectorSell54,193$48.82$2,645,702.26  
9/13/2021Elena ProkupetsDirectorSell6,660$50.07$333,466.20  
9/10/2021Elena ProkupetsDirectorSell2,550$50.00$127,500.00  
8/20/2021Malcolm SalterDirectorSell755$40.73$30,751.1513,672  
8/2/2021Elena ProkupetsDirectorSell4,257$45.01$191,607.57  
8/2/2021Stewart FisherInsiderSell18,104$45.00$814,680.00  
7/29/2021Elena ProkupetsDirectorSell11,336$45.00$510,120.00  
7/29/2021Jolie SiegelInsiderSell12,500$45.00$562,500.00  
7/16/2021Malcolm SalterDirectorSell755$37.37$28,214.3514,427  
7/1/2021Adam CrystalInsiderSell15,000$37.98$569,700.0015,000  
6/18/2021Malcolm SalterDirectorSell755$37.19$28,078.4514,843  
5/21/2021Malcolm SalterDirectorSell755$37.12$28,025.6015,598  
4/5/2021Adam CrystalInsiderSell15,000$37.77$566,550.0015,000  
10/6/2020Marc A CohenDirectorBuy5,030$19.00$95,570.00
10/6/2020William MckeeCFOBuy5,263$19.00$99,997.00
(Data available from 1/1/2013 forward)
speech bubbles
speech bubbles











C4 Therapeutics (NASDAQ:CCCC) Insider Trade Frequently Asked Questions

Who is on C4 Therapeutics's Insider Roster?

The list of insiders at C4 Therapeutics includes Adam Crystal, Elena Prokupets, Jolie Siegel, Malcolm Salter, Marc A Cohen, Stewart Fisher, and William Mckee.Learn more on CCCC's insiders

What percentage of C4 Therapeutics stock is owned by insiders?

21.04% of C4 Therapeutics stock is owned by insiders. Learn more on CCCC's insider holdings

Which C4 Therapeutics insiders have been buying company stock?

The following insiders have purchased C4 Therapeutics stock in the last 24 months: Marc A Cohen ($95,570.00), and William Mckee ($99,997.00).

How much insider buying is happening at C4 Therapeutics?

Insiders have purchased a total of 10,293 C4 Therapeutics shares in the last 24 months for a total of $195,567.00 bought.

Which C4 Therapeutics insiders have been selling company stock?

The following insiders have sold C4 Therapeutics stock in the last 24 months: Adam Crystal ($1,136,250.00), Elena Prokupets ($4,868,432.97), Jolie Siegel ($562,500.00), Malcolm Salter ($115,069.55), and Stewart Fisher ($814,680.00).

How much insider selling is happening at C4 Therapeutics?

Insiders have sold a total of 163,781 C4 Therapeutics shares in the last 24 months for a total of $7,496,932.52 sold.

This page was last updated on 9/24/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.